Rush MD Anderson Cancer Center at Rush Lisle is a clinical research site located in Lisle, Illinois, United States 60532.
Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.
Rush MD Anderson Cancer Center at Rush Lisle has participated in 9 clinical trials with 9 currently active.
Therapeutic areas: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Recurrent Head and Neck Squamous Cell Carcinoma.
Sponsors: National Cancer Institute (NCI), NRG Oncology, ECOG-ACRIN Cancer Research Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Lisle
Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rush MD Anderson Cancer Center at Rush Lisle has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush MD Anderson Cancer Center at Rush Lisle has 9 clinical trials on record, with 9 currently active. Their work covers Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Recurrent Head and Neck Squamous Cell Carcinoma.
Rush MD Anderson Cancer Center at Rush Lisle has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.